ES2172002T3 - Composicion farmaceutica que contiene lornoxicam y una sal disodica del acido etilendiamintetraacetico. - Google Patents

Composicion farmaceutica que contiene lornoxicam y una sal disodica del acido etilendiamintetraacetico.

Info

Publication number
ES2172002T3
ES2172002T3 ES97943820T ES97943820T ES2172002T3 ES 2172002 T3 ES2172002 T3 ES 2172002T3 ES 97943820 T ES97943820 T ES 97943820T ES 97943820 T ES97943820 T ES 97943820T ES 2172002 T3 ES2172002 T3 ES 2172002T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
aintetraacetic
ethylene
acid
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97943820T
Other languages
English (en)
Inventor
Hermann Ruckendorfer
Philippus Egger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Austria GmbH
Original Assignee
Nycomed Austria GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Austria GmbH filed Critical Nycomed Austria GmbH
Application granted granted Critical
Publication of ES2172002T3 publication Critical patent/ES2172002T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE EXPONE UNA COMPOSICION FARMACEUTICA QUE CONTIENE LORNOXICAM Y UNA SAL DISODICA DEL EDTA.
ES97943820T 1996-09-03 1997-09-01 Composicion farmaceutica que contiene lornoxicam y una sal disodica del acido etilendiamintetraacetico. Expired - Lifetime ES2172002T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0156496A ATA156496A (de) 1996-09-03 1996-09-03 Pharmazeutische zusammensetzung

Publications (1)

Publication Number Publication Date
ES2172002T3 true ES2172002T3 (es) 2002-09-16

Family

ID=3516134

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97943820T Expired - Lifetime ES2172002T3 (es) 1996-09-03 1997-09-01 Composicion farmaceutica que contiene lornoxicam y una sal disodica del acido etilendiamintetraacetico.

Country Status (12)

Country Link
EP (1) EP0934079B1 (es)
JP (1) JP4122062B2 (es)
CN (1) CN1108822C (es)
AT (2) ATA156496A (es)
AU (1) AU4552597A (es)
CA (1) CA2264626C (es)
DE (1) DE59706450D1 (es)
DK (1) DK0934079T3 (es)
ES (1) ES2172002T3 (es)
NO (1) NO326350B1 (es)
PT (1) PT934079E (es)
WO (1) WO1998009654A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001172183A (ja) * 1999-12-21 2001-06-26 Wakamoto Pharmaceut Co Ltd 眼科用医薬組成物
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
JO2735B1 (en) 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
EP4378443A2 (en) 2009-10-12 2024-06-05 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
WO2012127496A1 (en) 2011-03-01 2012-09-27 Cadila Healthcare Limited Stable pharmaceutical compositions of lornoxicam or salts thereof
CN106727364B (zh) * 2016-12-02 2020-01-24 苏州天马医药集团天吉生物制药有限公司 一种注射用氯诺昔康的冻干工艺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1203703B (it) * 1983-05-23 1989-02-15 Bruschettin Srl Composizione farmaceutica a carattere di collirio ad azione antiinfiammatoria,e procedimento per la sua preparazione
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
AU5774796A (en) * 1995-06-13 1997-01-09 Dyer, Alison Margaret Pharmaceutical compositions containing lornoxicam and cyclod extrin

Also Published As

Publication number Publication date
CN1228710A (zh) 1999-09-15
DK0934079T3 (da) 2002-04-02
EP0934079A1 (de) 1999-08-11
AU4552597A (en) 1998-03-26
ATE213420T1 (de) 2002-03-15
CA2264626C (en) 2009-03-24
CN1108822C (zh) 2003-05-21
NO326350B1 (no) 2008-11-17
DE59706450D1 (de) 2002-03-28
NO990909L (no) 1999-02-25
ATA156496A (de) 1997-10-15
EP0934079B1 (de) 2002-02-20
CA2264626A1 (en) 1998-03-12
JP4122062B2 (ja) 2008-07-23
WO1998009654A1 (de) 1998-03-12
NO990909D0 (no) 1999-02-25
JP2000517331A (ja) 2000-12-26
PT934079E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
MX9306499A (es) Composiciones farmaceuticas que contienen una anfetamina.
HN1997000110A (es) Derivados del acido arilsulfoonilamino hidroxamico
GT199800126A (es) Terapia de combinacion.
ES2172002T3 (es) Composicion farmaceutica que contiene lornoxicam y una sal disodica del acido etilendiamintetraacetico.
EA199700186A1 (ru) Новые дипептидные амидины, используемые в качестве ингибиторов тромбина
DE69429359T2 (de) Orale zubereitungen von antimykotika
ES2135347B1 (es) Hidroxifeniltriazinas.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
DE69405732T2 (de) Herstellung von perfluor(alkylvinylethern)
NO953371L (no) Anvendelse av anti-konvulsiva ved behandling av neuro-AIDS
ATE234625T1 (de) Glp-1 zusammensetzungen mit verlängerter wirkdauer
DE69926859D1 (de) Gebissreinigungsmittel
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ES2143833T3 (es) Acidos y esteres de la diosmetina y composiciones farmaceuticas que los contienen.
EP0858262A4 (en) THROMBIN INHIBITORS
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
AR009819A1 (es) Inhibidores de la proteasa proteinicos estabilizados y sus variantes
TNSN89009A1 (fr) Utilisation d'inhibiteurs de l'enzyme de conversion de l'angiotensine
ES541436A0 (es) Procedimiento para preparar un agente farmaceutico que con- tiene un inhibidor de la enzima convertidora de angiotensina
AR018304A2 (es) Acido clavulanico y composicion que lo contiene
DK440989A (da) Dopamin-beta-hydroxylase inhibitorer
ES2170377T3 (es) Composicion que contiene quitosana.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 934079

Country of ref document: ES